StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jefferies on Boston Scientific (BSX): ICTx segment emerges as a double-digit growth engine
March 16, 2026 4:25 PM
Jefferies analyst Matthew Taylor reiterated a Buy rating and $120.00 price target on Boston Scientific (NYSE: BSX)The analyst commented, "We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
